Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $457.24 thousand as of April 29, 2026. Its market cap has decreased by -32.79% in one year.

Market Cap

457.24K

Enterprise Value

1.24M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.07

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 457.24K, a decrease of -99.73%. That is a compound annual growth rate of -39.68%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	457.24K	-13.50%
Dec 31, 2025	528.62K	40.64%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sorrento Therapeutics	489.34K
CNBX Pharmaceuticals	490.31K
Actavia Life Sciences	385.91K
EV Biologics	511.27K
Bio-Path Holdings	521.76K
Regenerative Medical Technology Group	525.56K
THC Farmaceuticals	326.37K
Eloxx Pharmaceuticals	608.63K

Market Cap Rankings